Erlotinib improves QOL in NSCLC

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1557, 2006-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib improves QOL in NSCLC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

QOL improves with additional SRL 172 in NSCLC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 454, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

QOL improves with additional SRL 172 in NSCLC

Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Erlotinib dominates docetaxel for NSCLC

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Erlotinib dominates docetaxel for NSCLC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite